SNY

Sanofi ADS
D

SNY

Arincen75/100B

Sanofi ADS balance sheet 1999–2026

Sanofi ADS had 5.97B EUR in cash and short-term investments on 30 September 2026, against total debt of 19.85B EUR: net debt of 13.88B EUR.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q3 FY2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Cash and equivalents
5.97B7.66B7.44B8.71B12.74B10.10B13.92B9.74B6.93B10.32B10.27B
Short-term investments
0.00810.00M486.00M0.000.000.000.000.000.000.00108.00M
5.97B8.47B7.93B8.71B12.74B10.10B13.92B9.74B6.93B10.32B10.38B
Cash growth
-33.01%+6.81%-8.99%-31.61%+26.12%-27.43%+42.84%+40.68%-32.86%-0.64%+12.28%
Receivables
326.00M11.05B10.63B11.04B10.75B9.79B9.95B10.08B9.35B8.68B9.05B
Inventory
25.02B10.21B9.43B9.67B8.96B8.72B8.35B7.99B7.48B6.82B6.89B
Other current assets
1.89B307.00M13.71B471.00M870.00M1.35B958.00M299.00M363.00M210.00M31.00M
Total current assets
33.21B30.95B42.59B30.66B34.03B30.56B33.70B28.61B24.58B26.35B26.69B
Property, plant and equipment
12.08B11.51B11.60B11.81B11.68B11.98B10.56B11.02B9.65B9.58B10.02B
Long-term investments
0.006.61B3.26B3.26B3.22B2.91B2.67B5.99B6.17B6.14B5.68B
Goodwill and intangibles
67.63B67.56B66.01B73.72B71.53B69.46B62.71B61.09B66.12B53.34B51.17B
Goodwill
—41.30B43.38B49.40B49.89B48.06B44.36B44.52B44.24B40.26B40.29B
Intangible assets
—26.26B22.63B24.32B21.64B21.41B18.34B16.57B21.89B13.08B10.88B
Other non-current assets
17.38B1.56B1.37B588.00M882.00M731.00M600.00M595.00M271.00M104.00M6.45B
Total assets
130.29B126.81B132.80B126.46B126.72B120.24B114.41B112.74B111.41B99.81B104.67B
Accounts payable
24.55B7.36B7.55B7.33B6.81B6.18B5.30B5.31B5.04B4.63B4.30B
Deferred revenue
0.000.000.000.00264.00M319.00M252.00M0.000.000.000.00
Short-term debt
3.35B4.34B4.21B2.32B4.45B3.45B3.00B4.82B2.63B1.28B1.76B
Other current liabilities
220.00M14.69B15.13B11.57B11.86B10.61B9.75B7.66B6.98B6.45B7.27B
Total current liabilities
29.77B28.35B29.16B24.19B23.96B21.30B19.25B20.38B17.38B15.46B16.43B
Long-term debt
14.59B14.25B11.79B14.35B14.86B17.12B19.75B20.13B21.99B14.31B16.78B
Other non-current liabilities
9.43B9.37B10.18B9.96B9.00B9.34B9.47B9.84B9.58B10.18B11.41B
Lease obligations, current
216.00M272.00M261.00M275.00M0.000.000.000.000.000.000.00
Lease obligations, long-term
1.69B1.47B1.65B1.76B1.90B1.84B931.00M987.00M18.00M20.00M34.00M
Total liabilities
57.05B55.10B54.94B52.11B51.57B51.21B51.16B53.63B52.37B41.57B46.95B
Common stock and paid-in capital
0.002.44B2.53B2.53B2.52B2.53B2.52B2.51B2.50B2.51B2.58B
Retained earnings
0.000.000.0067.50B66.73B63.01B60.15B51.78B53.11B52.86B51.48B
Accumulated other comprehensive income
0.0064.44B70.56B4.88B6.11B3.55B782.00M4.51B3.43B2.71B5.00B
Shareholders' equity
72.88B71.38B77.51B74.04B74.78B68.68B63.11B58.93B58.88B58.07B57.55B
Minority interest
362.00M334.00M350.00M313.00M368.00M350.00M146.00M174.00M159.00M169.00M170.00M
19.85B20.33B17.91B18.70B21.21B22.41B23.68B25.93B24.64B15.60B18.58B
Net cash
-13.88B-11.86B-9.98B-9.99B-8.48B-12.32B-9.76B-16.19B-17.72B-5.29B-8.20B
Working capital
3.44B2.61B13.43B6.46B10.06B9.27B14.46B8.23B7.20B10.89B10.25B
Book value per share
30.3729.2430.9729.4729.8727.4225.1723.5823.6123.1022.37
Tangible book value
5.25B3.82B11.49B317.00M3.25B-782.00M401.00M-2.16B-7.25B4.73B6.39B
Tangible book value per share
2.191.564.590.131.30-0.310.16-0.86-2.911.882.48
Current ratio
1.121.091.461.271.421.441.751.401.411.701.62
Debt to equity
0.270.280.230.250.280.330.380.440.420.270.32

Figures in EUR at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Common questions about Sanofi ADS's cash and debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.